Pfizer Inc. (BKK:PFIZER19)

Market Cap	4.50T
Revenue (ttm)	2.08T
Net Income (ttm)	350.29B
Shares Out	n/a
EPS (ttm)	61.71
PE Ratio	12.86
Forward PE	8.77
Dividend	0.23 (1.41%)
Ex-Dividend Date	Jul 25, 2025

Volume	18,236
Average Volume	306,145
Open	15.90
Previous Close	16.10
Day's Range	15.80 - 16.00
52-Week Range	15.10 - 18.00
Beta	n/a
RSI	43.66
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: PFIZER19

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD